Alexandria Real Estate stock holds steady as investors await catalysts.
Published on 07/16/2026 at 02:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Alexandria Real Estate Equities, Inc. (ISIN US0152711022) is a major life science real estate landlord listed on the NYSE under the ticker ARE.
Business model
The company owns and develops properties designed for laboratory and office use, with demand tied to biotechnology, pharmaceutical, and research tenants. That makes the stock more exposed to life science leasing trends than to broad office real estate sentiment.
Market context
For US investors, Alexandria sits in a distinct REIT niche rather than the general office segment, which is the key analytical difference for the shares. The company has also been a familiar name in institutional portfolios because of its concentration in innovation clusters.
Alexandria Real Estate profile and filings
Review the company profile, investor materials, and other background on Alexandria Real Estate Equities, Inc.
Representative property type
Alexandria's core product is specialized lab and office space for life science tenants, including campus-style properties in major research markets. That real estate mix is the defining operating lever for revenue growth and occupancy trends.
Shares and listing
Alexandria Real Estate Equities, Inc. trades on the New York Stock Exchange as ARE. As of July 16, 2026, no verified live price is available in this article.
Fact box
- Company: Alexandria Real Estate Equities, Inc.
- ISIN: US0152711022
- Ticker: ARE
- Exchange: NYSE
- Sector / Industry: Real Estate / Office REIT
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
